Center-Authored Papers

Filters: Author is Gale, Robert Peter  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Inamoto Y, Flowers MED, Wang T, Urbano-Ispizua A, Hemmer MT, Cutler CS, Couriel DR, Alousi AM, Antin JH, Gale RP et al..  2015.  Tacrolimus versus cyclosporine after hematopoietic cell transplantation for acquired aplastic anemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
S
Vrooman LM, Millard HR, Brazauskas R, Majhail NS, Battiwalla M, Flowers ME, Savani BN, Akpek G, Aljurf M, Bajwa R et al..  2017.  Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less Than Three Years of Age.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Ayas M, Eapen M, Le-Rademacher J, Carreras J, Abdel-Azim H, Alter BP, Anderlini P, Battiwalla M, Bierings M, Buchbinder DK et al..  2015.  Second allogeneic hematopoietic cell transplantation for Patients with Fanconi anemia and Bone Marrow Failure.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
R
Koreth J, Pidala J, Perez WS, Deeg HJ, Garcia-Manero G, Malcovati L, Cazzola M, Park S, Itzykson R, Ades L et al..  2013.  Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(21):2662-70. Abstract
Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang M-J et al..  2012.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.. Blood. 119(1):296-307. Abstract
Kanate AS, Mussetti A, Kharfan-Dabaja MA, Ahn KW, DiGilio A, Beitinjaneh A, Chhabra S, Fenske TS, Freytes C, Gale RP et al..  2015.  Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched unrelated donors.. Blood. Abstract
Klyuchnikov E, Bacher U, Kröger NM, Hari PN, Woo Ahn K, Carreras J, Bachanova V, Bashey A, Cohen JB, D'Souza A et al..  2015.  Reduced-intensity allografting as first transplantation approach in relapsed/refractory grade 1-2 follicular lymphoma provides improved outcomes in long-term survivors.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
P
Lee SJ, Storer B, Wang H, Lazarus HM, Waller EK, Isola LM, Klumpp TR, Umejiego JBC, Savani BN, Loren AW et al..  2013.  Providing personalized prognostic information for adult leukemia survivors.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(11):1600-7. Abstract
O
Shaw PJ, Kan F, Woo Ahn K, Spellman SR, Aljurf M, Ayas M, Burke M, Cairo MS, Chen AR, Davies SM et al..  2010.  Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.. Blood. 116(19):4007-15. Abstract
N
Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang M-J, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R et al..  2015.  New cancers after autotransplantations for multiple myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(4):738-45. Abstract
M
Cornell RF, D'Souza A, Kassim AA, Costa LJ, Innis-Shelton RD, Zhang M-J, Huang J, Abidi M, Aiello J, Akpek G et al..  2016.  Maintenance Versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
L
Cheng YC, Shi Y, Zhang M-J, Brazauskas R, Hemmer MT, Bishop MR, Nieto Y, Stadtmauer E, Ayash L, Gale RP et al..  2017.  Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation.. Journal of Cancer. 8(6):1009-1017. Abstract
I
Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F et al..  2017.  Increasing use of allogeneic hematopoietic cell transplantation in patients age 70 years and older in the United States.. Blood. Abstract
Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M et al..  2015.  Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(2):266-74. Abstract
Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP et al..  2008.  Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.. Blood. 112(8):3500-7. Abstract
Hamadani M, Saber W, Woo Ahn K, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN et al..  2013.  Impact of Pretransplant Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III Follicular Lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Bachanova V, Burns LJ, Woo Ahn K, Laport GG, Akpek G, Kharfan-Dabaja MA, Nishihori T, Agura E, Armand P, Jaglowski SM et al..  2015.  Impact of pre-transplant FDG-PET status on outcomes after allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Urbano-Ispizua A, Pavletic SZ, Flowers ME, Klein JP, Zhang M-J, Carreras J, Montoto S, Perales M-A, Aljurf MD, Akpek G et al..  2015.  The Impact of Graft Versus Host Disease on Relapse Rate in Patients with Lymphoma Depends on the Histological Sub-Type and the Intensity of the Conditioning Regimen.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
H
Smith SM, Burns LJ, van Besien K, Le Rademacher J, He W, Fenske TS, Suzuki R, Hsu JW, Schouten HC, Hale GA et al..  2013.  Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(25):3100-9. Abstract
Saad A, Mahindra A, Zhang M-J, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ et al..  2013.  Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
G
Cutler C, Kesselheim A, Gabardi S, Andersson BS, Carpenter PA, Khoury HJ, Litzow M, Rowley SD, Lanum S, Leather H et al..  2011.  Generic immunosuppressants in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):285-90.
D
Sabloff M, Sobecks RM, Woo Ahn K, Zhu X, DeLima M, Brown JR, Inamoto Y, Holland KH, Aljurf MD, Laughlin MJ et al..  2014.  Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(3):421-4. Abstract
Deol A, Sengsayadeth S, Woo Ahn K, Wang H-L, Aljurf M, Antin JH, Battiwalla M, Bornhauser M, Cahn J-Y, Camitta B et al..  2016.  Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis. Cancer. Abstract
C
Michelis FV, Gupta V, Zhang M-J, Wang H-L, Aljurf M, Bacher U, Beitinjaneh A, Chen Y-B, DeFilipp Z, Gale RP et al..  2017.  Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.. Cancer. Abstract
Copelan EA, Avalos BR, Woo Ahn K, Zhu X, Gale RP, Grunwald MR, Hamadani M, Hamilton BK, Hale GA, Marks DI et al..  2015.  Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(3):552-8. Abstract